Accessibility Menu
 
Dynavax Technologies logo

Dynavax Technologies

(NASDAQ) DVAX

Current PriceN/A
Market CapN/A
Since IPO (2004)-84%
5 Year+58%
1 Year+18%
1 Month+1%

Dynavax Technologies Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$330.51M

Net Income (TTM)

$43.40M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

DVAX: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Dynavax Technologies

Industry

Biotechnology

Employees

405

CEO

Ryan Spencer

Headquarters

EmeryVille, CA 94608, US

DVAX Financials

Key Financial Metrics (TTM)

Gross Margin

83%

Operating Margin

3%

Net Income Margin

-13%

Return on Equity

-8%

Return on Capital

1%

Return on Assets

-5%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Short Interest

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$227.80M

Operating Income

$4.12M

EBITDA

$45.70M

Operating Cash Flow

$66.51M

Capital Expenditure

$6.35M

Free Cash Flow

$60.16M

Cash & ST Invst.

$713.83M

Total Debt

$254.42M

Dynavax Technologies Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2025YOY CHG

Revenue

$94.88M

+17.7%

Gross Profit

$80.47M

+19.1%

Gross Margin

84.82%

N/A

Market Cap

N/A

N/A

Market Cap/Employee

N/A

N/A

Employees

405

N/A

Net Income

$26.93M

+53.0%

EBITDA

$31.89M

+35.3%

Quarterly Fundamentals

Name
Q3 2025YOY CHG

Net Cash

$362.79M

-29.4%

Accounts Receivable

$73.32M

-2.6%

Inventory

$73.29M

+17.4%

Long Term Debt

$244.95M

-2.1%

Short Term Debt

$40.07M

N/A

Return on Assets

-4.59%

N/A

Return on Invested Capital

1.24%

N/A

Free Cash Flow

$32.59M

+79.9%

Operating Cash Flow

$33.83M

+73.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
AMPHAmphastar Pharmaceuticals, Inc.
$19.01-2.66%
COLLCollegium Pharmaceutical, Inc.
$32.44-2.93%
BBNXBeta Bionics, Inc.
$10.76-6.60%
PCRXPacira BioSciences, Inc.
$22.88-1.84%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$38.78-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$8.28+0.05%
ARTLArtelo Biosciences
$10.54+2.30%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$11.56-0.06%

Questions About DVAX

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.